Articles & Presentations
IMS works with a variety of media outlets and trade associations to share expertise on issues impacting the pharmaceutical industry. This section provides abstracts and PDFs of current published articles, as well as extracts from recent industry presentations.
Special Report: Public Relations Evaluation -
Free Thinking
A number of factors in the pharmaceutical industry are driving a re-evaluation of both the traditional marketing mix and the emphasis given specific tools in the communications portfolio.
Jan 26, 2005
Withdrawal Syndrome
Although product withdrawals put the pharma industry under the microscope, it's essential to balance the tougher safety standards that the public demands with new tools for managing risk, or innovation will stall, according to IMS's Murray Aitken.
Jan 17, 2005
To Market, To Market: The Seven Steps of Launch Effectiveness
Seven steps have been identified to launching a pharmaceutical product into the marketplace successfully. More precisely, seven sets of activities exist involving commercial research and analysis which, when performed appropriately and at the right times, will help a product reach its market potential.
Jan 1, 2005
Taking Market Assessment to the Next level: An Example From the Dyslipidemia Market
The cornerstone of a successful marketing program is a rich understanding of the market. Traditionally, marketers have relied on dispensed prescription, epidemiological, and primary market research data to assess disease markets.
Jan 1, 2005
The Brand Team's Secret Weapon for Enhancing Market Performance
This IMS report in Product Management Today presents an approach that brand managers can employ to segment the market into groups and subgroups of physicians.
Dec 15, 2004
Forecast 2005
Over the past few years, the battle over US pharmaceutical prices has focused on importation. There is a widespread perception that importation is the primary threat to free pricing.
Dec 1, 2004
Anonymous Patient-Level Data and the Biologics Market: Answers at Last
Assessing the performance of a biologic product presents a unique challenge for marketers. Traditional data sources, such as dispensed retail prescriptions data, cannot be used to measure performance of a biologic drug, because they only capture prescriptions dispensed at the pharmacy.
Dec 1, 2004
Pharma Leadership Forum: IMS's Aitken Challenges Industry to Lead Healthcare Reform
Addressing senior-level execs from the US pharma and biotech industries, Murray Aitken, Sr. VP, corporate strategy, articulated the value of information in advancing healthcare -- and advised the audience to review, and rethink, its leadership role.
Nov 19, 2004
It's All in the Details
This IMS report in Pharmaceutical Executive outlines the conversion of data into knowledge, a critical step in successful job performance.
Nov 12, 2004
Pharmaceutical Sales and the New World of Physician Marketing
The pharmaceutical industry has reached a major crossroads: income growth is declining. The raditional growth drivers that have served the industry well in the past are yielding less, and the time for new, long-term, sustainable growth opportunities is clearly at hand.
Nov 1, 2004
|
| 
more
